Fact CheckerSign in

NCT06576050Completed

WeighT LOSS Surgery and Comprehensive Cardiometabolic Responses to to EXercise

A Prospective Evaluation of Subjects Undergoing Weight Loss Surgery to Determine Cardiometabolic Responses to Exercise

Source: ClinicalTrials.gov · Last updated 13 Aug 2026

Brief summary (registry, in English)

The goal of this study is to define how treatment of obesity impacts cardiometabolic performance during exercise in patients with established HFpEF or at risk for HFpEF. Multi-dimensional physical activity, including 6 minute walk distance, resting metabolic rate, the metabolic cost of initiating exercise, and low-level, intermediate, peak exercise, and recovery oxygen utilization patterns will be examined in relation to weight loss in people having bariatric surgery. The investigators also aim to learn more about the relationship between obesity, exercise intolerance, and heart failure with preserved ejection fraction (HFpEF). The investigators are interested in the extent to which HFpEF\'s manifestations are preventable or reversible with weight-loss interventions. The main questions it aims to answer are: 1. How does weight loss surgery affect comprehensive measures of physical activity? 2. What are the biochemical signatures of obesity and their reversibility in patients with HFpEF and obesity?

Status (registry)
Completed
Study type
Observational
Enrollment
21 (actual)
First submitted
26 Aug 2024
Start date
25 Jan 2022
Primary completion date
2 Aug 2024
Lead sponsor
Massachusetts General Hospital
NCT number
NCT06576050

What you commit to

  • Study type: Observational
  • Participants enrolled: 21
  • From 25 Jan 2022 to the primary completion date, 2 Aug 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous Bariatric surgery

Other illness

  • Inability to perform exercise testing on a cycle ergometer (i.e. orthopedic conditions that preclude cycling or walking, recent systemic illness that compromises exercise capacity).
  • Any contraindication to performing exercise testing or any history of ventricular arrhythmia, any recent (within the last 3 months) or untreated supraventricular arrhythmia, elevated blood pressure at the time of presentation for exercise testing (\>155 mmHg systolic, or \>95 mmHg diastolic blood pressure), active or recent exacerbation of congestive heart failure, or history of reactive airways disease that is induced by exercise).
    • Acute myocardial infarction (3-5 days) or unstable angina
    • Uncontrolled symptomatic arrhythmias
    • Active endocarditis
    • Acute myocarditis or pericarditis
    • Symptomatic severe aortic stenosis
    • Acute pulmonary embolism or DVT
    • Suspected dissecting aneurysm
    • Uncontrolled asthma
    • Room air desaturation to \<85%
    • Acute non-cardiopulmonary disorder that may affect exercise performance (infection, orthopedic problem)

Lab values

  • History of systolic heart failure, past or present LVEF of \<40%

Other

  • Pregnancy

Who the study is looking for

  • Patients scheduled for weight loss surgery (gastric sleeve procedure)
  • 40 years or older
  • PMH one or more of the following:
    • Diabetes Mellitus
    • Hypertension requiring medical treatment
    • Age \>65 years
    • History of HFpEF
    • Echocardiographic findings: left atrial enlargement (LAE), left ventricular hypertrophy (LVH), or right ventricular systolic pressure \>40 mmHg (RVSP)

Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Massachusetts General Hospital
Coordinator of this site? Confirm its status
BostonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.